Ad is loading...
DNLI
Price
$25.05
Change
-$3.40 (-11.95%)
Updated
Nov 15 closing price
106 days until earnings call
GLSI
Price
$12.56
Change
-$1.03 (-7.58%)
Updated
Nov 15 closing price
One day until earnings call
Ad is loading...

DNLI vs GLSI

Header iconDNLI vs GLSI Comparison
Open Charts DNLI vs GLSIBanner chart's image
Denali Therapeutics
Price$25.05
Change-$3.40 (-11.95%)
Volume$1.1M
CapitalizationN/A
Greenwich LifeSciences
Price$12.56
Change-$1.03 (-7.58%)
Volume$43.99K
CapitalizationN/A
DNLI vs GLSI Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DNLI vs. GLSI commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Sell and GLSI is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (DNLI: $25.05 vs. GLSI: $12.56)
Brand notoriety: DNLI and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 126% vs. GLSI: 155%
Market capitalization -- DNLI: $3.61B vs. GLSI: $165.1M
DNLI [@Biotechnology] is valued at $3.61B. GLSI’s [@Biotechnology] market capitalization is $165.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, DNLI is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 2 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • GLSI’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than GLSI.

Price Growth

DNLI (@Biotechnology) experienced а -20.10% price change this week, while GLSI (@Biotechnology) price change was -12.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

GLSI is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.61B) has a higher market cap than GLSI($165M). GLSI YTD gains are higher at: 19.392 vs. DNLI (16.729). GLSI has higher annual earnings (EBITDA): -10.53M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. GLSI (7.23M). DNLI has higher revenues than GLSI: DNLI (1.27M) vs GLSI (0).
DNLIGLSIDNLI / GLSI
Capitalization3.61B165M2,185%
EBITDA-486.71M-10.53M4,620%
Gain YTD16.72919.39286%
P/E RatioN/AN/A-
Revenue1.27M0-
Total Cash896M7.23M12,401%
Total Debt48.8MN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIGLSI
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 5 days ago
86%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NAIGX28.23-0.04
-0.14%
Nuveen International Value A
GRHAX13.35-0.10
-0.74%
Goehring & Rozencwajg Resources Retail
CISMX14.64-0.13
-0.88%
Clarkston Partners Institutional
AWSHX64.27-0.73
-1.12%
American Funds Washington Mutual A
WTRCX13.89-0.19
-1.35%
Delaware Ivy Core Equity Fund Class C

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-11.95%
BEAM - DNLI
63%
Loosely correlated
-8.59%
ALEC - DNLI
59%
Loosely correlated
-17.21%
NTLA - DNLI
56%
Loosely correlated
-7.61%
JANX - DNLI
55%
Loosely correlated
-4.58%
RCKT - DNLI
54%
Loosely correlated
-5.67%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ORMP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-7.58%
ORMP - GLSI
35%
Loosely correlated
-4.50%
ETNB - GLSI
34%
Loosely correlated
-9.37%
DNLI - GLSI
32%
Poorly correlated
-11.95%
SAGE - GLSI
31%
Poorly correlated
-5.03%
NAUT - GLSI
30%
Poorly correlated
-6.50%
More